Following the loss of TMT1B expression in thyroid cancer cells, a significant decrease in proliferation was found, similar to effects seen in non-small cell lung cancer, clear cell renal cancer, and glioma cells (4, 21–23, 26–29, 32, 33, 50). Here, TMT1B is linked to thyroid gland carcinoma.